Innocan Pharma Corp (CSE: INNO )
0.2300
+0.0100
(+4.55%)
Official Closing Price
Updated: 11:02 AM EDT, Aug 9, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore News
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
April 23, 2024
Via Benzinga
Exposures
Product Safety
Performance
More NewsRead More
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
February 13, 2024
Via Benzinga
Exposures
Product Safety
More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It
October 23, 2023
Via Benzinga
Topics
Cannabis
CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare
September 21, 2023
Via Benzinga
Innovative Delivery Systems Create Unique Opportunities in the Billion-Dollar Pain Market (CSE: INNO)
November 14, 2022
Via AB Newswire
Topics
Cannabis
Exposures
Cannabis
Innocan Pharma Provides an Operational Update
September 21, 2022
Via Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada
August 11, 2021
Via Newsfile
Topics
Supply Chain
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|